At close: December 13 at 4:00:02 PM EST
After hours: 7:58:11 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.07 | -0.28 | -2.98 | -1.15 |
| Low Estimate | -0.07 | -0.28 | -2.98 | -1.15 |
| High Estimate | -0.07 | -0.28 | -2.98 | -1.15 |
| Year Ago EPS | -0.68 | -1.69 | -13.22 | -2.98 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 14.53M | 11.5M | 39.31M | 47.06M |
| Low Estimate | 13.9M | 11M | 38.7M | 46M |
| High Estimate | 15.16M | 12M | 39.92M | 48.12M |
| Year Ago Sales | 10.6M | 7.91M | 34.07M | 39.31M |
| Sales Growth (year/est) | 37.13% | 45.35% | 15.38% | 19.71% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.85 | -0.71 | -0.35 | -0.94 |
| EPS Actual | -0.68 | -1.69 | -1.08 | -0.81 |
| Difference | 0.17 | -0.98 | -0.73 | 0.13 |
| Surprise % | 19.91% | -137.61% | -207.34% | 13.43% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.07 | -0.28 | -2.98 | -1.15 |
| 7 Days Ago | -0.07 | -0.28 | -2.98 | -1.15 |
| 30 Days Ago | -0.17 | -0.35 | -3.36 | -1.25 |
| 60 Days Ago | -0.17 | -0.35 | -3.36 | -1.25 |
| 90 Days Ago | -0.17 | -0.35 | -3.36 | -1.25 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BFRI | 89.72% | 83.40% | 77.46% | 61.41% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Reiterates | Benchmark: Buy to Buy | 11/15/2024 |
| Reiterates | Benchmark: Buy to Buy | 8/16/2024 |
| Reiterates | Benchmark: Buy to Buy | 8/31/2023 |
Related Tickers
PTPI Petros Pharmaceuticals, Inc.
0.3298
-5.83%
SXTC China SXT Pharmaceuticals, Inc.
0.3850
-4.54%
CPIX Cumberland Pharmaceuticals Inc.
2.3800
+9.17%
GELS Gelteq Limited
2.7400
-10.16%
PRFX PainReform Ltd.
3.1100
+6.51%
UPC Universe Pharmaceuticals INC
0.7715
-4.78%
SBFM Sunshine Biopharma, Inc.
2.7500
+1.48%
AKAN Akanda Corp.
1.4900
-4.49%
CTOR Citius Oncology, Inc.
1.1100
+3.74%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.6847
-6.44%